Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6834991 | 0.98 | TSHR (0.56) | TSHRL3MBTL1LMNAALDH1A1RECQL | |
| SCHEMBL30291868 | 0.98 | TSHR (0.56) | TSHRL3MBTL1LMNAALDH1A1RECQL | |
| SCHEMBL10626764 | 0.98 | TSHR (0.56) | TSHRL3MBTL1LMNAALDH1A1RECQL | |
| SCHEMBL1368882 | 0.98 | TSHR (0.56) | TSHRL3MBTL1LMNAALDH1A1RECQL | |
| SCHEMBL1308174 | 0.93 | TSHR (0.61) | TSHRL3MBTL1LMNAALDH1A1RECQL | |
| SCHEMBL322568 | 0.84 | TSHR (0.57) | TSHRL3MBTL1LMNAALDH1A1RECQL | |
| SCHEMBL12504110 | 0.83 | L3MBTL1 (0.39) | TSHRL3MBTL1LMNAALDH1A1PABPC1 | |
| SCHEMBL12504186 | 0.83 | L3MBTL1 (0.39) | TSHRL3MBTL1LMNAALDH1A1PABPC1 | |
| SCHEMBL29227996 | 0.81 | TSHR (0.56) | TSHRL3MBTL1LMNAALDH1A1RECQL | |
| SCHEMBL28085552 | 0.81 | TSHR (0.56) | TSHRL3MBTL1LMNAALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4523027-A | Purification of carboxylates containing aldehydes, acetals and/or unsaturated compounds | BASF AKTIENGESELLSCHAFT (DE) | 1985-06-11 | — | — | US | claimed |
| EP-0101910-B1 | PROCESS FOR THE PURIFICATION OF CARBOXYLIC-ACID ESTERS CONTAINING ALDEHYDES, ACETALS AND/OR UNSATURATED COMPOUNDS | BASF Aktiengesellschaft (DE) | 1985-04-03 | — | — | EP | claimed |
| EP-0030330-B1 | PROCESS FOR PREPARING CARBOXYLIC ACID ESTERS CONTAINING ALDEHYDES AND/OR ACETALS | BASF Aktiengesellschaft (DE) | 1983-08-24 | — | — | EP | claimed |
| US-4350572-A | Purification of carboxylic acid esters containing aldehydes and/or acetals | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | claimed |
| US-20220402862-A1 | IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES | INTELLIA THERAPEUTICS, INC. | 2022-12-22 | — | — | US | disclosed |
| US-20220402862-A1 | IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES | INTELLIA THERAPEUTICS, INC. | 2022-12-22 | — | — | US | disclosed |
| US-11420933-B2 | Lipids and lipid compositions for the delivery of active agents | NOVARTIS AG (CH) | 2022-08-23 | — | — | US | disclosed |
| EP-4019506-A1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | Novartis AG (CH) | 2022-06-29 | — | — | EP | disclosed |
| EP-4019506-A1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | Novartis AG (CH) | 2022-06-29 | — | — | EP | disclosed |
| EP-3959191-A1 | IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES | Intellia Therapeutics, Inc. (US) | 2022-03-02 | — | — | EP | disclosed |
| CN-114127044-A | Ionizable amine lipids and lipid nanoparticles | 英特利亚治疗股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| EP-3083579-B1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | NOVARTIS AG (CH) | 2022-01-26 | — | — | EP | disclosed |
| US-4523027-A | Purification of carboxylates containing aldehydes, acetals and/or unsaturated compounds | BASF AKTIENGESELLSCHAFT (DE) | 1985-06-11 | — | — | US | disclosed |
| EP-0065319-B1 | PROCESS FOR THE PREPARATION OF AN UNSATURATED MACROCYCLIC KETONE | FIRMENICH SA (CH) | 1984-10-17 | — | — | EP | disclosed |
| EP-0065319-A1 | Process for the preparation of an unsaturated macrocyclic ketone | FIRMENICH SA (CH) | 1982-11-24 | — | — | EP | disclosed |
| US-4350572-A | Purification of carboxylic acid esters containing aldehydes and/or acetals | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | disclosed |
| US-4346023-A | FLAVORS, PERFUMES | FIRMENICH SA (CH) | 1982-08-24 | — | — | US | disclosed |
| US-4302607-A | CYCLOPENTADECANONES | FIRMENICH SA (CH) | 1981-11-24 | — | — | US | disclosed |
| EP-0015412-A2 | Unsaturated macrocyclic ketones; their preparation; preparation of saturated macrocyclic ketones; application in perfume and flavour compositions of some unsaturated macrocyclic ketones | FIRMENICH SA (CH) | 1980-09-17 | — | — | EP | disclosed |
| US-4138418-A | Process for the preparation of ω,ω-dialkoxycarboxylic acid derivatives | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11420933-B2 | Lipids and lipid compositions for the delivery of active agents | LPAR1, LPAR4, LIPA | TSHR 1257/4885L3MBTL1 1553/4885LMNA 316/4885 |
| US-20220402862-A1 | IONIZABLE AMINE LIPIDS AND LIPID NANOPARTICLES | PHOSPHO1, SGMS1, SGMS2 | TSHR 2588/4885L3MBTL1 2440/4885LMNA 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.